6 - 8 September 2010, Izmir, Turkey

Course Objectives

This educational course summarizes the contemporary situation in the epidemiology, pathogenesis and treatment of meningitis.

Course Venue

Anemon Otel, Ege University, Faculty of Medicine
Izmir, Turkey

Target Audience

Up to 50 postgraduates or senior trainees of infectious diseases and/or clinical microbiology

Registration Fee

EUR 375 for ESCMID, EKMUD and Turkish Society of Hospital Infection and Control members

EUR 425 for all others

The fee includes scientific sessions, accommodation and meals but not travel.

CME Accreditation

The organizer of the course will apply for European CME accreditation through EACCME.

Oguz Resat Sipahi
Dept. of Infectious Diseases and clinical Microbiology
Ege University
35100 Izmir
Turkey

Phone +90 533 467 7266

Oguz Resat Sipahi 

 Course Programme

Monday 6 September 2010

• 13:00 - 13:15 Welcome & Introduction.
• 13:15-14:45 Epidemiology of acute purulent meningitis in developed and under developed countries:
  community-acquired - Hakan Leblebicioglu
  hospital-acquired -  Dilek Arman
• 15:15 - 17:15 Pathogenesis and pathophysiology of meningitis (including animal models)
  (I) bacterial-host interaction (a microbiologic perspective)
  (II+III) early and late events or mechanisms of immune regulation (II) and  tissue destruction (III).
  Susanna Ricci, Stephen Leib & Uwe Koedel
• 17:30 - 18:15 Clinical presentation of meningitis (including hospital-acquired meningitis):
  in adults - Serhat Unal
  in children - Marceline van Furth

Tuesday 7 September 2010

• 8:30 - 9:30 Diagnosis of meningitis (including PCR and other novel approaches).
  Christian Østergaard
• 10:00 - 12:00 Treatment of community-acquired meningitis, including guidelines and diffucult to treat organisms like penicilin resistant pneumococci:
  ID Perspective - Stephen Leib & Stefan Zimmerli
  ICU and neurological perspective - Matthias Klein
  Paediatric Perspective: Modern treatment of Paediatric Bacterial Menegitis - Heikki Peltola
• 13:30-14:30 Treatment of hospital-acquired meningitis, including guidelines and difficult to treat organisms like MRSA, VRE and multidrug resistant gram negatives.
  Oguz Resat Sipahi
• 15:00 - 16:45 Complications-including short term and long term complications.
  Matthias Klein
  Current and future trends in adjunctive therapy of meningitis.
  Heikki Peltola
• from 17:15 on Social Programme

Wednesday 8 September 2010

• 8:30 - 9:30 Vaccinology in meningitis
  Mehmet Ceyhan
• 9:45 - 10:45 Fungal meningitis
  Stefan Zimmerli
• 11:00 - 12:30 Epidemiology, clinical presentation (I), diagnosis (II) and treatment (III) of chronic meningitis.
  Gaye Usluer, Tanil Kocagoz and Hakan Erdem
• 12:30 - 12:45 Course evaluation

• Dilek Arman, Ankara, TR
• Mehmet Ceyhan, Ankara, TR
• Hakan Erdem, Ankara, TR
• Marceline van Furth, Amsterdam, NL
• Matthias Klein, Munich, DE
• Tanil Kocagoz, Istanbul, TR
• Uwe Koedel, Munich, DE
• Hakan Leblebicioglu, Samsun, TR
• Stephen Leib, Bern, CH
• Christian Østergaard, Copenhagen, DK
• Heikki Peltola, Helsinki, FI
• Susanna Ricci, Siena, IT
• Oguz Resat Sipahi, Izmir, TR
• Serhat Unal, Ankara, TR
• Gaye Usluer, Eskisehir, TR
• Stefan Zimmerli, Bern, CH